Medical Aesthetics is proud to include the revolutionary Dermasculpt Microcannula for application in their current services. The novel device can effectively address the needs of their clients who want to improve his or her appearance, but are afraid of the sharp needle tip.
Online PR News – 24-January-2014 – New York – Medical Aesthetics announces that they will introduce the use of the revolutionary Dermasculpt Microcannula this December. Customers who dread sharp needles can now undergo a variety of facial rejuvenation and dermal filler procedures without facing their biggest fear. This device is effective against those numerous side effects associated with the hypodermic needles and paves the way towards the minimally invasive facial rejuvenation procedures of tomorrow.
The highlight of Dermasculpt Microcannula resides in the blunt tip end, a feature that allows physicians to utilize a single point of entry into the epidermis for wider coverage. The tip’s shape along with its incredible flexibility permits surgeons to glide the microcannula gently under the patient’s skin for a more consistent and even spreading of the dermal filler. Dermasculpt Microcannula can be utilized with all dermal fillers available on the market, irrespective of their level of viscosity and ingredients.
The utilization of blunt tip cannulas for soft-tissue augmentation purposes is widespread and very popular in Europe. Until recently, the use of these devices has been disapproved in the United States. The rationale for this decision was the high risk of excessive swelling and bruising that certain facial regions are prone to when injected with a pre-packaged filler agent. Dermasculpt Microcannula is among the few blunt tip end devices that have been approved by the FDA. The device was deemed safe to use in administering various dermal fillers, including Juvederm, Restylane or Radiesse.
Numerous cosmetic surgeons in the US report that these cannulas help yield better results in certain procedures, such as the deeper injections necessary in regions like the infra-orbital area or the cheeks. The use of the traditional hypodermic needle in the aforementioned regions presented the high risk of damaging a blood vessel. The sharp tip of the traditional needle made the procedure rather painful and demanded the use of an anesthetic.
The Dermasculpt Microcannula devices not only reduce the chances of perforating a blood vessel with the needle, but also make the dermal filler injection less painful and more comfortable for patients. The Skin Sculpting Technique incorporated in the microcannulas allows the practitioner to reshape the epidermis by recreating volume, erasing wrinkles and improving the saggy skin appearance.
Patients who want to take advantage of the new technology or would like to learn more about how they can integrate the use of this device into their future facial augmentation procedure can contact Dr. Leslie Gerstman at (212) 966-3991 or visit her office at 349 E Northfield Ave, Suite 120 Livingston, New Jersey.